Target intelligence / Profile preview

Escherichia coli DNA primase allosteric magnesium-binding site (DnaG allosteric Mg site)

Target
DnaG allosteric Mg site
Molecular classification
Enzyme, DNA-directed RNA polymerase, TOPRIM domain-containing protein
01

Overview

The Escherichia coli primase (DnaG) allosteric magnesium-binding site is a critical regulatory region within the essential bacterial enzyme responsible for synthesizing RNA primers during DNA replication (Griep and Lokey, 1995). DnaG is a DNA-dependent RNA polymerase that functions as a molecular brake to coordinate the activities of the replisome on the leading and lagging strands. The enzyme contains a conserved TOPRIM domain, which includes a cluster of acidic residues that coordinate magnesium ions (Mg2+) essential for catalytic activity (CDD:240127). Biochemical studies have shown that DnaG binds at least two magnesium ions in a cooperative manner, where an allosteric magnesium-binding site induces a conformational change necessary for the enzyme to transition into its high-affinity, catalytically active state (Griep and Lokey, 1995). This site is a target for several small-molecule inhibitors, including the natural product SCH 642305 and various polyphenols, which disrupt the enzyme's function and halt bacterial proliferation (Chu et al., 2003; MDPI Molecules, 2018). Because the structure of bacterial DnaG is distinct from the human primase complex, this allosteric site represents a promising target for the development of selective, narrow-spectrum antibiotics to combat E. coli infections.

Other names
DnaG allosteric siteTOPRIM allosteric magnesium sitePrimase allosteric pocketMagnesium-binding site of DnaG
02

Mechanism of action

Allosteric inhibition of RNA primer synthesis by preventing the cooperative binding of magnesium ions and the subsequent conformational activation of the DnaG enzyme.

03

Biological functions

DNA replication initiationRNA primer synthesisCoordination of leading and lagging strand synthesis (molecular brake)Conformational regulation of enzyme activity
04

Disease associations

Infection
05

Safety considerations

Potential off-target inhibition of human topoisomerases due to TOPRIM domain conservationDevelopment of antibiotic resistance via mutations in the dnaG genePoor bioavailability and cell permeability of certain inhibitors like suramin
06

Interacting drugs

SCH 642305

6 more in the full profile.

07

Biomarkers

RNA primer synthesis levelsBacterial DNA replication rateBacterial growth inhibition (Minimum Inhibitory Concentration, MIC)

Beyond the preview

Go deeper on Escherichia coli DNA primase allosteric magnesium-binding site (DnaG allosteric Mg site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli DNA primase allosteric magnesium-binding site (DnaG allosteric Mg site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call